Tidomet CR Tablet is primarily used in the treatment of Parkinson’s disease. Parkinson’s disease is a disorder of the central nervous system that affects movement and locomotion, causing stiffness, tremors, difficulty walking, impaired coordination, and impaired balance.

Tidomet CR Tablet contains 'Levodopa' and 'Carbidopa'. Levodopa is converted into dopamine in the brain and helps regulate movement. Carbidopa acts by preventing the breakdown of Levodopa in the bloodstream, allowing more Levodopa to reach the brain.

The most common side effects of Tidomet CR Tablet are nausea, vomiting, loss of appetite, light-headedness, lowered blood pressure, confusion, and dyskinesia (uncontrolled/involuntary muscle movement). Most of these side effects do not require medical attention. However, talk to your doctor if you experience these side effects persistently.

If you are known to be allergic to any of the components in Tidomet CR Tablet , please inform your doctor. If you are pregnant or breastfeeding, it is advised to consult your doctor.

Tidomet CR Tablet is used in the treatment of Parkinson’s disease. The detailed uses of Tidomet CR Tablet are as follows:

• Management of Parkinson’s disease: Tidomet CR Tablet is commonly prescribed to ease symptoms of Parkinson’s, such as tremors, stiffness, and difficulty with movement.
• Improvement of Quality of Life: Tidomet CR Tablet supports an improved quality of life by helping individuals perform daily activities more efficiently.
• Reduction of Motor Fluctuations: Tidomet CR Tablet effectively minimises on-off periods in Parkinson’s patients, stabilising movement and reducing episodes of immobility.
• Assistance with Bradykinesia: Tidomet CR Tablet helps alleviate bradykinesia, a symptom characterised by slow movements, which is prevalent in Parkinson’s disease.
• Adjunct Therapy: Tidomet CR Tablet can complement other Parkinson’s disease medications, enhancing overall treatment outcomes and symptom management.

• Tidomet CR Tablet can be taken with or without food as advised by your doctor.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow Tidomet CR Tablet as a whole with a glass of water.
• Do not chew, crush, or break it.

• Tidomet CR Tablet is an anti-Parkinson's agent that is used in the treatment of Parkinson's disease, with its symptoms including tremors, spasms, muscle stiffness, and poor muscle control.
• Tidomet CR Tablet is a combination of two medicines, namely 'Levodopa' and 'Carbidopa'.
• Levodopa is converted into dopamine in the brain and helps regulate movement.
• Carbidopa acts by preventing the breakdown of Levodopa in the bloodstream so that more Levodopa can effectively reach the brain to block acetylcholine (a chemical messenger in the brain).

• Tell your doctor if you have any medical history of diabetes, heart attacks, mental illness, stomach ulcers, heart disease, or have recently undergone a surgical procedure.
• After taking Tidomet CR Tablet , one may feel lightheaded, so it is advisable to avoid any work that requires mental alertness.
• Patients taking Tidomet CR Tablet can also have a low level of vitamin B12 and increased methylmalonic acid levels. Additionally, prolonged intake of Tidomet CR Tablet may increase the risk of nerve damage.
• Tidomet CR Tablet should be given with caution in patients with eye problems (narrow-angle glaucoma), irregular heartbeat (arrhythmia), gastrointestinal bleeding, and psychosis.
• The use of Tidomet CR Tablet is restricted if a person takes monoamine oxidase inhibitors (MAOs) or antidepressant drugs like isocarboxazid, phenelzine, selegiline, and tranylcypromine because it can lead to a high blood pressure (hypertension) crisis.